José Domingo
Pedreira Andrade
Publicacións (121) Publicacións de José Domingo Pedreira Andrade
2020
-
How well are we performing the initial assessment of HIV-positive patients? Results from a multicentre cohort in Spain
HIV Medicine, Vol. 21, Núm. 2, pp. 128-134
2019
2018
-
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study
American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522
-
Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients
Medicine (United States), Vol. 97, Núm. 38
-
Low-level viremia is associated with clinical progression in HIV-infected patients receiving antiretroviral treatment
Journal of Acquired Immune Deficiency Syndromes, Vol. 78, Núm. 3, pp. 329-337
2017
-
Real life experience with direct-acting antivirals agents against hepatitis C infection in elderly patients
Journal of Clinical Virology, Vol. 88, pp. 58-61
-
Tendencia de las hospitalizaciones, reingresos y mortalidad intrahospitalaria en los pacientes infectados por VIH entre 1993-2013: impacto de la coinfección por el virus de la hepatitis C
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 35, Núm. 1, pp. 20-26
-
Viral dynamics among hepatitis C virus chronic infected patients during direct-acting antiviral agents therapy: Impact for monitoring and optimizing treatment duration
European Journal of Gastroenterology and Hepatology, Vol. 29, Núm. 7, pp. 781-785
2016
-
Any impact of blips and low-level viraemia episodes among HIV-infected patients with sustained virological suppression on ART?
Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 4, pp. 1051-1055
-
European mitochondrial haplogroups impact on liver fibrosis progression among HCV and HIV/HCV-coinfected patients from Northwest Spain
Journal of Acquired Immune Deficiency Syndromes, Vol. 73, Núm. 2, pp. 149-153
-
Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma
Hepatology, Vol. 63, Núm. 2, pp. 488-498
-
Liver Retransplantation in Patients with HIV-1 Infection: An International Multicenter Cohort Study
American Journal of Transplantation, Vol. 16, Núm. 2, pp. 679-687
-
Liver toxicity and risk of discontinuation in HIV/hepatitis C virus-coinfected patients receiving an etravirine-containing antiretroviral regimen: Influence of liver fibrosis
HIV Medicine, Vol. 17, Núm. 1, pp. 62-67
-
Long-term clinical experience with darunavir (2007–2015) in a large cohort of HIV-infected patients in Spain
Journal of Medical Virology, Vol. 88, Núm. 12, pp. 2125-2131
2015
-
Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study
PLoS ONE, Vol. 10, Núm. 10
-
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
PLoS Medicine, Vol. 12, Núm. 3
-
Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): A randomised, open-label, non-inferiority trial
The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 785-792
-
Lung cancer in patients living with HIV infection
AIDS
-
Molecular characterization of HIV-1 infection in Northwest Spain (2009-2013): Investigation of the subtype F outbreak
Infection, Genetics and Evolution, Vol. 30, pp. 96-101
-
Trends on epidemiological, virological, and clinical features among newly diagnosed HIV-1 persons in Northwest Spain over the last 10 years
Journal of Medical Virology, Vol. 87, Núm. 8, pp. 1319-1326